Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Trading Update

19 Jan 2010 07:00

RNS Number : 7435F
Cello Group plc
19 January 2010
 



19 January 2010

  

Cello Group plc

Pre-Close trading update - year ended 31 December 2009

Cello Group plc (AIM: CLL, 'the Group'),  the leading independent market research and consulting group, today publishes the following pre-close trading update for the year ended 31 December 2009 Since the announcement of the Group's interim results published in early September, there has been a marked pick up in its market research activity from a wide range of domestic and international clients, in addition to continued strength in the core pharmaceutical operation. However, this has been offset by a challenging period for aspects of the Tangible division of the Group, most notably in financial services and certain charity related work where the traditional seasonal pick up in client activity was not as robust as anticipated. The Tangible operations based in Scotland have had a strong year. Total Group revenue is expected to be in the region of £60.0m.

As highlighted in the interim results, the Group's cost reduction programme continued in the second halfThe total cost base in 2009 is expected to be between £4.0m and £4.5m lower than 2008 as a result of reduced headcount and property consolidation, which will give rise to an exceptional cost of around £1.9m.

As a result, the Board anticipates that the Group's headline profit before tax will be approximately £5.0m.The Group's strong cash conversion continued in the second half of 2009, as a result of which the Board expects to report year end net debt of between £11.5m and £12.0m, down from £14.8m on 30 June 2009.Whilst the Board remains realistically cautious about the current outlook and it is too early to give detailed guidance for 2010, the Group is seeing refreshed levels of spend across major research clients, with pharmaceutical and health related research showing particular strengthThe pipeline of research work is significantly stronger than at the same time last year. Therefore, following the substantial reduction in low margin and non-profitable activities, the Group is in a strong position to push for organic growth in 2010. The Group expects to announce its preliminary results for the year ended 31 December 2009 on Wednesday 17 March 2010. 

 

Enquiries:

 

Cello Group 

 020 7812 8460

Mark ScottChief Executive

Mark Bentley, Finance Director

 

Altium 

 020 7484 4040

Ben Thorne

Paul Chamberlain

 

College Hill

 020 7457 2020

Adrian Duffield/Rozi Morris

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEAXFPFELEEFF
Date   Source Headline
14th May 20137:00 amRNSBoard Appointment
14th May 20137:00 amRNSAGM STATEMENT
10th May 20132:28 pmRNSAdditional Listing/TVR
23rd Apr 20137:00 amRNSHolding(s) in Company
19th Apr 20137:00 amRNSFace Launches Pulsar TRAC
12th Apr 20131:03 pmRNSAnnual Report and Accounts 2012
9th Apr 20137:00 amRNSDirector/PDMR Shareholding
2nd Apr 201312:44 pmRNSHolding(s) in Company
27th Mar 201310:00 amRNSHolding(s) in Company
20th Mar 20137:00 amRNSDirector/PDMR Shareholding
13th Mar 20137:00 amRNSPreliminary Results for the Year Ended 31 Dec 2012
1st Mar 20137:00 amRNSTotal Voting Rights
28th Jan 20137:00 amRNSPre-close trading update
28th Jan 20137:00 amRNSAcquisition of Mash Health
19th Dec 20129:50 amRNSHolding(s) in Company
14th Nov 20127:00 amRNSHealthcare Seminar
1st Oct 201212:29 pmRNSShare Option Grants
20th Sep 20129:09 amRNSDirector/PDMR Shareholding
19th Sep 20122:13 pmRNSDividend Timetable
19th Sep 20127:01 amRNSCello's Talking Taboos
19th Sep 20127:00 amRNSInterim Results 2012
3rd Sep 20128:30 amRNSNotice of Interim results
12th Jul 20122:21 pmRNSShare Option Grants
11th Jul 20127:00 amRNSTrading update
1st Jun 20127:00 amRNSTotal Voting Rights
24th May 20127:00 amRNSAdditional listing / TVR
16th May 201210:07 amRNSResult of AGM
15th May 20127:00 amRNSAGM Statement
1st May 20127:00 amRNSAdditional Listing
17th Apr 20127:00 amRNSAnnual Financial Report
27th Mar 20127:00 amRNSHolding(s) in Company
14th Mar 20127:00 amRNSDirector/PDMR Shareholding
13th Mar 20127:00 amRNSLaunch of CSR programme
13th Mar 20127:00 amRNSFinal Results
24th Jan 201212:59 pmRNSNotice of Results
23rd Jan 20127:01 amRNSYear end trading update
21st Dec 20117:00 amRNSDirectorate Change
19th Dec 20117:00 amRNSChange of Adviser
1st Nov 201111:30 amRNSHolding in Company
18th Oct 20117:00 amRNSHolding in Company
4th Oct 20117:00 amRNSDirector/PDMR Shareholding
21st Sep 201110:30 amRNSDirector/PDMR Shareholding
10th Aug 201110:37 amRNSNotice of Results
13th Jul 20117:00 amRNSDirector/PDMR Shareholding
6th Jul 20117:00 amRNSTrading update
14th Jun 20117:00 amRNSShare Option Grants
3rd Jun 201110:10 amRNSTotal Voting Rights
26th May 20117:00 amRNSAnalyst and investor teach-in
17th May 20111:23 pmRNSResult of AGM
17th May 20117:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.